GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Boundless Bio Inc (NAS:BOLD) » Definitions » Earnings Yield (Joel Greenblatt) %
中文

Boundless Bio (Boundless Bio) Earnings Yield (Joel Greenblatt) %

: 0.00% (As of Dec. 2023)
View and export this data going back to 2024. Start your Free Trial

Boundless Bio's Enterprise Value for the quarter that ended in Dec. 2023 was $0.00 Mil. Boundless Bio's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-28.75 Mil. Boundless Bio's Earnings Yield (Joel Greenblatt) for the quarter that ended in Dec. 2023 was 0.00%.

The historical rank and industry rank for Boundless Bio's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:

BOLD' s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: -28.9   Med: 0   Max: 0
Current: -27.62

BOLD's Earnings Yield (Joel Greenblatt) % is ranked worse than
62.48% of 1394 companies
in the Biotechnology industry
Industry Median: -15.91 vs BOLD: -27.62

Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.

A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. Boundless Bio's Forward Rate of Return (Yacktman) % for the quarter that ended in Dec. 2023 was 0.00%. The Forward Rate of Return uses the normalized Free Cash Flow of the past seven years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.


Boundless Bio Earnings Yield (Joel Greenblatt) % Historical Data

The historical data trend for Boundless Bio's Earnings Yield (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Boundless Bio Annual Data
Trend Dec21 Dec22 Dec23
Earnings Yield (Joel Greenblatt) %
- - -

Boundless Bio Quarterly Data
Dec21 Jun22 Sep22 Dec22 Jun23 Sep23 Dec23
Earnings Yield (Joel Greenblatt) % Get a 7-Day Free Trial - - - - -

Competitive Comparison

For the Biotechnology subindustry, Boundless Bio's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Boundless Bio Earnings Yield (Joel Greenblatt) % Distribution

For the Biotechnology industry and Healthcare sector, Boundless Bio's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where Boundless Bio's Earnings Yield (Joel Greenblatt) % falls into.



Boundless Bio Earnings Yield (Joel Greenblatt) % Calculation

In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.

Boundless Bios Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Dec. 2023 is calculated as

Earnings Yield (Joel Greenblatt)=EBIT/Enterprise Value
=-54.796/0
= %

Boundless Bio's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-28.75 Mil.



Boundless Bio  (NAS:BOLD) Earnings Yield (Joel Greenblatt) % Explanation

Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.

Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.


Be Aware

Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.

Forward Rate of Return (Yacktman) % based on Don Yacktman's definition is a better measure of the expected rate of return for a stock.


Boundless Bio Earnings Yield (Joel Greenblatt) % Related Terms

Thank you for viewing the detailed overview of Boundless Bio's Earnings Yield (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.


Boundless Bio (Boundless Bio) Business Description

Industry
Comparable Companies
Traded in Other Exchanges
N/A
Address
Boundless Bio Inc is a clinical-stage oncology company. It is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the significant unmet need in patients with oncogene amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in more than 14% of cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

Boundless Bio (Boundless Bio) Headlines

From GuruFocus